C.X.L. van Assche

Kruger, D. N., Bosman, M., Van Assche, C. X. L., Wesley, C. D., Cillero-Pastor, B., Delrue, L., Heggermont, W., Bartunek, J., De Meyer, G. R. Y., Van Craenenbroeck, E. M., Guns, P.-J., & Franssen, C. (2024). Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice. Cardio-Oncology, 10(1), Article 40. https://doi.org/10.1186/s40959-024-00241-1

Van Assche, C. X. L., Krüger, D. N., Flinders, B., Vandenbosch, M., Franssen, C., Guns, P. J. D., Heeren, R. M. A., & Cillero-Pastor, B. (2024). Improved on-tissue detection of the anti-cancer agent doxorubicin by quantitative matrix-assisted laser desorption/ionization mass spectrometry imaging. Talanta, 271, Article 125667. https://doi.org/10.1016/j.talanta.2024.125667

Bosman, M., Krüger, D., Van Assche, C., Boen, H., Neutel, C., Favere, K., Franssen, C., Martinet, W., Roth, L., De Meyer, G., Cillero-Pastor, B., Delrue, L., Heggermont, W., Van Craenenbroeck, E., & Guns, P.-J. (2023). Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers. Cardiovascular Research, 119(15), 2579-2590. https://doi.org/10.1093/cvr/cvad136

Van der Stede, T., Spaas, J., de Jager, S., De Brandt, J., Hansen, C., Stautemas, J., Vercammen, B., De Baere, S., Croubels, S., Van Assche, C.-H., Pastor, B. C., Vandenbosch, M., Van Thienen, R., Verboven, K., Hansen, D., Bove, T., Lapauw, B., Van Praet, C., Decaestecker, K., ... Derave, W. (2023). Extensive profiling of histidine-containing dipeptides reveals species- and tissue-specific distribution and metabolism in mice, rats, and humans. Acta Physiologica, 239(1), Article e14020. https://doi.org/10.1111/apha.14020